Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Factors Predicting Survival of Patients with Gastric Cancer

  • Published : 2014.07.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Gastric cancer is one of the most common causes of cancer death in Taiwan. The literature has previously shown that age, tumor site, T categories, and number of metastatic nodes significantly affect prognosis. The aim of this study was to determine the long-term survival of patients with gastric cancer, as well as the effect of particular prognostic factors on survival. Materials and Methods: This was a survival analysis study with retrospective design. We reviewed the records of 64 patients with adenocarcinoma of the stomach who had undergone gastrectomy with curative intent between 2009 and 2012 at a teaching hospital in southern Taiwan. Data extracted from patient documents included age, gender distribution, tumor location, and pathological grading. Results: The median follow-up time was 4 years, and there were 31 deaths attributed to gastric cancer. Kaplan-Meier analysis revealed that retrieval of less than 15 lymph nodes from a patient was a significant predictor of survival. A significant predictor of poorer survival was higher pathological grading. Conclusions: Our results indicate that the number of lymph nodes retrieved and pathological grading could be viewed as crucial prognostic factors affecting the survival of individuals with gastric cancer.

Keywords

References

  1. Alatengbaolide, Lin D, Li Y, et al (2013). Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes. Am J Clin Oncol, 36, 325-30. https://doi.org/10.1097/COC.0b013e318246b4e9
  2. Calik M, Calik I, Demirci1 E, Altun E et al (2014). Goseki grade and tumour location influence survival of patients with gastric cancer. Asian Pac J Cancer Prev, 15, 1429-34. https://doi.org/10.7314/APJCP.2014.15.3.1429
  3. Coburn NG, Swallow CJ, Kiss A, Law C (2006). Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer, 107, 2143-51. https://doi.org/10.1002/cncr.22229
  4. de Steur WO, Dikken JL, Hartgrink HH (2013). Lymph node dissection in resectable advanced gastric cancer. Dig Surg, 30, 96-103. https://doi.org/10.1159/000350873
  5. Etemadi M,Pourian1 M, Shakib A et al (2014). A registry program for familial gastric cancer patients referred to cancer institute of iran. Asian Pac J Cancer Prev, 15, 2124-44. https://doi.org/10.7314/APJCP.2014.15.5.2141
  6. Health Promotion Administration Ministry of Health and Welfare (Taiwan). (2014). Cancer registry annual report, 2011, Taiwan.
  7. Lee HK, Yang HK, Kim WH et al (2001). Influence of the number of lymph nodes examined on staging of gastric cancer. Br J Surg, 88, 1408-12. https://doi.org/10.1046/j.0007-1323.2001.01875.x
  8. Ministry of Health and Welfare (2013, July 17th). Top ten cancer report of prevalence and incident (Accessed on May 21, 2014).
  9. Son T, Hyung WJ, Lee JH et al (2012). Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer. Cancer, 118, 4687-93. https://doi.org/10.1002/cncr.27426
  10. Stephens MR, Lewis WG, White S et al (2005). Prognostic significance of alarm symptoms in patients with gastric cancer. Br J Surg, 92, 840-6. https://doi.org/10.1002/bjs.4984
  11. Smith DD, Schwarz RR, Schwarz RE (2005). Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: Data from a large US-population database. J Clin Oncol, 23, 7114-24. https://doi.org/10.1200/JCO.2005.14.621
  12. Shen JY, Kim S, Cheong JH et al (2007). The impact of total retrieved lymph nodes on staging and survival of patients with pT3 gastric cancer. Cancer, 110, 745-51. https://doi.org/10.1002/cncr.22837
  13. Taiwan Cancer Registry (2013). Analysis of 2007-2011 new diagnosed survival rates of Top 10 cancer in 2012.
  14. Volpe CM, Driscoll DL, Douglass HO (2010). Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes. Ann Surg Oncol, 7, 139-44.
  15. Zare A, Mahmoodi M, Mohammad K, et al (2013). Survival analysis of patients with gastric cancer undergoing surgery at the Iran Cancer Institute: a method based on multi-state models. Asian Pac J Cancer Prev, 14, 6369-73. https://doi.org/10.7314/APJCP.2013.14.11.6369
  16. Zhang, YF, Shi J, Yu HP et al (2012). Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus. World J Gastroenterol, 18, 3602-9. https://doi.org/10.3748/wjg.v18.i27.3602
  17. Zhu HP, Xia X, Yu CH et al (2011). Application of Weibull model for survival of patients with gastric cancer. BMC Gastroenterol, 11, 1-6. https://doi.org/10.1186/1471-230X-11-1

Cited by

  1. Prognostic Value of Preoperative Inflammation-Based Prognostic Scores on Hospital Mortality after Gastric Cancer Surgery vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7909
  2. Relationship of Amplification and Expression of the C-MYC Gene with Survival among Gastric Cancer Patients vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7061
  3. Manganese Superoxide Dismutase (MnSOD Val-9Ala) Gene Polymorphism and Susceptibility to Gastric Cancer vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.485
  4. IL-1B (C+3954T) Gene Polymorphism and Susceptibility to Gastric Cancer in the Iranian Population vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.841
  5. Treatment Outcomes and Survival Study of Gastric Cancer Patients: A Retrospective Analysis in an Endemic Region vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.2055
  6. The GPX1 Pro198Leu polymorphism in gastric cancer patients with and without Helicobacter pylori infection vol.39, pp.11, 2017, https://doi.org/10.1007/s13258-017-0594-8
  7. Surgical treatment outcomes of patients with T1-T2 gastric cancer: does the age matter when excellent treatment results are expected? vol.16, pp.1, 2018, https://doi.org/10.1186/s12957-018-1388-4
  8. Changing trends in clinico-pathologic characteristics and treatment outcomes in patients with gastric cancer: A single-center, public hospital, retrospective study vol.14, pp.2, 2018, https://doi.org/10.14216/kjco.18013